Genesist

We had an incredible experience pitching at the NIH stage and connecting with inspiring professionals and innovators at BIO International Convention 2024! Thank you to NIH SEED, The National Institutes of Health and BIO-E Capstone for this amazing support and opportunity. Special thanks to the NIH and BioECapstone team for making this possible. Thank you to everyone who supported us along the way especially Thomas Webster Talmesha Richards, Ph.D. Nakia Melecio Eric Padmore, MHSA , Anne-Marie Maman and our incredible mentor Stanley Maloy. #Cancer #NIHPitch #BioECapstone #Innovation #BIO2024 #BioInternationalConvention #HealthcareInnovation #Biotech #CellTherapy

Genesist has won the Golden Ticket from BioLabs at the Yale Innovation Summit 2024! We extend our deepest gratitude to BioLabs (BioLabs New Haven, Johannes Fruehauf, and Mary Ann Melnick) and Yale Ventures for this incredible honor. Thanks to everyone who has supported us on this journey—our advisors, partners, mentors and the amazing Genesist team. Your unwavering support and belief in our mission have been invaluable. Thank you to Yale Ventures for hosting another excellent Innovation Summit! We are excited to continue our work with this great support, pushing the boundaries of cancer therapy. #BioLabs #YaleInnovationSummit #YaleVentures #CancerResearch #Innovation #CancerTherapy

? 2023 Wrap-Up: A Year of Milestones and Gratitude! As we bid farewell to an extraordinary year, we can't help but reflect on the incredible journey Genesist has had. Kicking off the year as part of the ABCT: Accelerator for Biosciences in Connecticut program was nothing short of spectacular. A special Thanks to Mary Howard, and Maggie El Naamani. The experience, coupled with being part of the stellar Nucleate cohort, enriched our perspectives and connected us with an inspiring global network. A special thanks to Nucleate New Haven, Stephen Lanahan, Anjali Ramaswamy, Yiting X., Andrew Hudak, and Xuefei Gao. Navigating the Eli Lilly and Company Genetic Medicine Grand Challenge through Nucleate was a highlight. In another exciting update, our recent round of animal studies was also a resounding success! This achievement marks a crucial step in our mission to revolutionize gene therapy. A heartfelt thank you to our incredible mentors and advisors for their invaluable guidance and unwavering support throughout this transformative year. ?? We're grateful for the lessons learned, the connections made, and the growth achieved. Here's to a fantastic 2023, filled with innovation, collaboration, and making strides in evolutionary medicine-based gene therapy! Happy New Year! #Genesist #Innovation #Biotech #GeneTherapy #CancerTherapy